Guidelines the submission of documentation for single technology assessment
Published:
|
Updated:
Changes
- : Updated submission guidelines
- : Revised guidelines
Guidelines
The guidelines and associated template for submission must be used when preparing and submitting documentation for single technology assessments of medicinal products for decisions regarding public sector funding via the National Insurance scheme (“Blåresept”) and the Regional Health Authorities ("Nye metoder").
The guidelines were last revised in November 2023.
New Norwegian EQ-5D-5L tariff will be mandatory from September 1st 2025
DMP is updating its submission guidelines for single technology assessments of medicinal products in the National Insurance Scheme (folketrygden), the specialist health service (New methods) and for health technology assessments of medical devices. From September 1st 2025, it will be mandatory to use the Norwegian EQ-5D-5L tariff (Garratt et al., 2024) for documenting health-related quality of life for adults in newly submitted documentation packages. For submission dossiers submitted before September 1st, the old guidelines apply. A transition to the new Norwegian EQ-5D-5L tariff also requires the use of updated norm data for age-adjusting utility weights and performing severity calculations. The tool for severity calculations and age adjustment of utility weights will be updated with current norm data and published on DMP's website.
Submission guidelines (effective until August 31)
Submission guidelines (effective from September 1)